Please assess the completion status of the following clinical trial:

Trial Title: Applied Relaxation for Vasomotor Symptoms

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* postmenopausal women (at least 12 months since last menstrual bleeding occurred or in previously hysterectomised women a serum follicle-stimulating hormone (S-FSH) defined as postmenopausal level according to references at the local laboratory)~* More or equal to 7 moderate to severe hot flashes or more or equal at 50 hot flashes per week according to a two-week screening diary~* ability to understand and speak Swedish~* freely given informed consent~Exclusion Criteria:~* unstable thyroid or other metabolic disease~* treatment with hormone therapy (HT) or other complementary- or alternative treatments treatment for menopausal-related symptoms~* treatment with psychopharmacological drugs and/or sedatives d-un-treated psychiatric disease~* frequently exercising women (≥ 2h high-intensity activities/week)

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Applied Relaxation (AR) (Type: EXPERIMENTAL): None
- Untreated Control Group (CG) (Type: NO_INTERVENTION): The women assigned to CG will be told to act as an untreated control group i.e. not to use hormonal treatment, other alternative medication, natural remedies for hot flashes and even not acupuncture, mind-body therapies or intensive physical activity.

Based on this trial design, predict the completion outcome and termination type (if applicable).